News + Filings Transactions Holdings
All 13F 13D/G Other
|
Opaleye Management Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/18/2022 |
SC 13G
| Opaleye Management Inc. reports a 5.3% stake in Larimar Therapeutics, Inc. |
01/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
09/18/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/31/2020 |
SC 13G
| Opaleye Management Inc. reports a 13% stake in TRACON PHARMACEUTICALS, INC. |
08/28/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/21/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/21/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
03/30/2020 |
SC 13G
| Opaleye Management Inc. reports a 5.1% stake in SEMLER SCIENTIFIC, INC. |
02/21/2020 |
SC 13G
| Opaleye Management Inc. reports a 5.6% stake in CIDARA THERAPEUTICS, INC. |
01/21/2020 |
SC 13G
| Opaleye Management Inc. reports a 5.1% stake in SANUWAVE HEALTH INC. |
12/27/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
11/22/2019 |
SC 13G
| Opaleye Management Inc. reports a 5.4% stake in FORTRESS BIOTECH, INC. |
11/07/2019 |
SC 13G
| Opaleye Management Inc. reports a 5.2% stake in EDAP TMS S.A. |
08/16/2019 |
SC 13G
| Opaleye Management Inc. reports a 6.2% stake in STEREOTAXIS, INC. |
05/24/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
05/03/2019 |
SC 13G
| Opaleye Management Inc. reports a 5.1% stake in OCULAR THERAPEUTIX, INC. |
01/22/2019 |
SC 13G
| Opaleye Management Inc. reports a 5.2% stake in AVENUE THERAPEUTICS, INC. |
10/03/2018 |
SC 13G
| Opaleye Management Inc. reports a 5.4% stake in CERECOR INC. |
09/07/2018 |
SC 13G
| Opaleye Management Inc. reports a 5.1% stake in IMPRIMIS PHARMACEUTICALS, INC. |
06/22/2018 |
SC 13G
| Opaleye Management Inc. reports a 5% stake in STRONGBRIDGE BIOPHARMA PLC |
06/22/2018 |
SC 13G
| Opaleye Management Inc. reports a 5% stake in FENNEC PHARMACEUTICALS INC. |
06/04/2018 |
SC 13G
| Opaleye Management Inc. reports a 7.8% stake in CIDARA THERAPEUTICS, INC. |
02/09/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/06/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/29/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
04/17/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
11/28/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
11/28/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|